These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6355192)

  • 1. A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia.
    Prentice HG
    J Clin Pathol; 1983 Nov; 36(11):1207-14. PubMed ID: 6355192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation for leukaemia in Europe. Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation.
    Lancet; 1988 Jun; 1(8599):1379-82. PubMed ID: 2898053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic marrow transplantation for the treatment of leukaemia. A review.
    Alvegård TA; Herzig GP; Graw RG
    Scand J Haematol; 1975 Nov; 15(4):287-305. PubMed ID: 789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
    Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The status of bone marrow transplantation for leukemia.
    McGlave PB
    Hosp Pract (Off Ed); 1985 Nov; 20(11):97-110. PubMed ID: 2997246
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of herpes simplex virus (HSV) infection in recipients of HLA-matched T-lymphocyte-depleted bone marrow allografts.
    Engelhard D; Morag A; Or R; Naparstek E; Cividalli G; Ruchlemer R; Aker M; Maayan S; Slavin S
    Isr J Med Sci; 1988 Mar; 24(3):145-50. PubMed ID: 3286577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic marrow transplantation for treatment of leukemia: results of the Munich Cooperative Group.
    Kolb HJ; Bender-Götze C; Haas RJ; Thierfelder S; Wilmanns W
    Haematol Blood Transfus; 1987; 30():204-12. PubMed ID: 3305196
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.
    Powles RL; Clink HM; Spence D; Morgenstern G; Watson JG; Selby PJ; Woods M; Barrett A; Jameson B; Sloane J; Lawler SD; Kay HE; Lawson D; McElwain TJ; Alexander P
    Lancet; 1980 Feb; 1(8164):327-9. PubMed ID: 6101787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mismatched bone marrow transplantation in children with hematologic malignancy using T lymphocyte depleted bone marrow.
    Trigg ME; Sondel PM; Billing R; Finlay JL; Peterson A; Hong R; Frierdich S; Shahidi N
    J Biol Response Mod; 1985 Dec; 4(6):602-12. PubMed ID: 3910764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation for treatment of leukemia in children.
    Trigg ME
    Pediatr Clin North Am; 1988 Aug; 35(4):933-48. PubMed ID: 3047659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious complications of human bone marrow transplantation.
    Winston DJ; Gale RP; Meyer DV; Young LS
    Medicine (Baltimore); 1979 Jan; 58(1):1-31. PubMed ID: 368507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bone marrow transplantation in childhood. Possibilities and risks].
    Friedrich W; Ebell W
    Monatsschr Kinderheilkd; 1987 May; 135(5):238-44. PubMed ID: 3302683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
    Champlin R; Gale RP
    Ann N Y Acad Sci; 1987; 511():447-58. PubMed ID: 2830829
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic bone marrow transplantation at Christchurch 1979-1985.
    Heslop HE; Heaton DC; Hart DN; Allen JR; Abbott GD; Beard ME
    N Z Med J; 1986 May; 99(801):318-21. PubMed ID: 3520412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
    Champlin RE; Mitsuyasu RT; Gale RP
    Prog Clin Biol Res; 1985; 193():315-25. PubMed ID: 3911215
    [No Abstract]   [Full Text] [Related]  

  • 19. Bone marrow transplantation. Problems and prospects.
    Kamani N; August CS
    Med Clin North Am; 1984 May; 68(3):657-74. PubMed ID: 6379337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow transplantation in the management of childhood cancer.
    Quinn JJ
    Pediatr Clin North Am; 1985 Jun; 32(3):811-33. PubMed ID: 3889807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.